Oaktree Capital Management »

Travere Therapeutics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $1.5M 1.5M 0.98